FDA & Trademarks: Lessons Learned from the Premium Cigar Industry

The cannabis and premium cigar industries have much in common: After a long history of being unregulated, each is getting its regulatory wake-up call. Through a discussion of challenges and real-world examples regarding trademark law, FDA regulation and other government oversight, this session will provide the marijuana sector with lessons learned by the premium cigar industry.

You’ll get insights on:

  • How a cannabis company can get ahead of future FDA regulations.
  • How to protect intellectual property when brands are essentially unprotectable at the federal level.
  • How a cannabis company can better avoid infringing on the trademarks or patents of others.
  • What other regulatory issues could be on the horizon.